PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Agency / Source: Eastern Biotech & Life Sciences FZ-LLC

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!

CancerSafe Test which is Panel of Tumor Markers for Women and Men Now Availlable in Middle East - In Dubai, Dubiotech based company Eastern Biotech & Life Sciences proudly announce Panel of cancer safe test time in Middle East
CancerSafe Test which is Panel of Tumor Markers for Women and Men Now Availlable in Middle East

 

NewswireToday - /newswire/ - Dubai, UAE, United Arab Emirates, 09/29/2007 - In Dubai, Dubiotech based company Eastern Biotech & Life Sciences proudly announce Panel of cancer safe test time in Middle East.

   
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.

PortaLIFE - The Best Of Life Sites for medicine, healthcare, life coaching, health social networking - PortaLIFE.com

 

Panel of Cancersafe test are really a fantastic tumor marker based test separately for Men and Women. Pankaj Sohaney, Manager marketing and Business Development said “If someone already have family history of cancer they must take check once for peace of mind”. Few laboratory and hospitals are performing individual markers test but its very innovative and novel product in terms of complete panel of cancer detection. One can know in very early stage for detection of cancer.
Dr. Sanjida Ahmed, Director of Research said now a days there is enough awareness among the people that Early detection of cancer is the only solution for cancer detection. Panel of cancer detection will diagnose gene mutation in early stage before it appears physically. It will help to reduce the number of cancer patients in future.

What is Cancersafe® test?
It is a highly sophisticated blood test to detect early cancer. Tumor markers have long been used, either to screen for cancers or to monitor cancer treatments, to track and screen for recurrences. Cancersafe® test uses a panel of 10/11 tumor markers (10 for women, 11 for men). Tumor markers are molecules appearing in the blood in relation to development of some of the most important cancers. Measurement or identification of tumor markers is useful, because it can detect substances in the blood in early stages, a signal that further medical attention is needed.

Cancersafe® test can also be useful in follow-up if you are being treated for the illness. Variations of the tumor markers can be followed by regular tests. Slight to moderate increase may occur 6-12 months before clinical signs of relapse.

Who would perform the test?
Everybody, especially over 40, also young women, caring about breast and ovary. Perform it once a year, or more if required, building your baseline and data for future: your report (since handling all results) will include graphs, demonstrating the evolution of the 10 (or 11) tumor markers: any abnormal increases would be an indication for medical consultation and further investigation.

How to collect the samples?
A normal blood sample from the arm is all that is required. It is very convenient, non-invasive and easy to obtain.

How long and how much?
Result and report is delivered, with comments (from 4 specialists), only two days after your serum specimen reaches the laboratory. For price list please check Price List.

Tests Options
• Panel for Women
• Panel for Men

Panel for Women
Everybody, specially over 40, even the young women, caring about breast and ovary should perform this test once a year. The result includes graphs demonstrating the evolution of the following tumor markers. This evolution should be highly considered for treatment and prognosis if the possibility of developing cancer is observed.

CEA, CA15-3, CA19-9, CA125, CA72-4, AFP, BHCG, B2M, NSE, CYFRA21-1
Panel for Men
All men, over 40, should perform it once a year, or more if required. This panel covers a wide range of cancers which are common in men. The evolution of the following tumor markers are demonstrated to screen for developing cancers in men.
CEA, CA19-9, CA125, CA72-4, PSA+ FPSA, AFP, BHCG, B2M, NSE, CYFRA 21-1

 
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.

PortaLIFE - The Best Of Life Sites for medicine, healthcare, life coaching, health social networking - PortaLIFE.com

 

Agency / Source: Eastern Biotech & Life Sciences FZ-LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


CancerSafe Test which is Panel of Tumor Markers for Women and Men Now Availlable in Middle East

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Pankaj Sohaney - EasternBiotech.com 
+97143692061 pankaj[.]easternbiotech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Eastern Biotech & Life Sciences FZ-LLC securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSS
AddThis press release: CancerSafe Test which is Panel of Tumor Markers for Women and Men Now Availlable in Middle EastAdd Health/Surgery News to My MSNAdd Health/Surgery News to My Yahoo!Add NewswireToday Health/Surgery Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner Twitter /NewswireToday

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!


Read Latest Articles From Eastern Biotech & Life Sciences FZ-LLC / Company Profile



Eastern Biotech Organize Seminar on Management of IEM & Comprehensive Newborn Screening
Over 75 Doctors from the UAE Attended CME Organized by Eastern Biotech & Life Sciences on Cancer
Eastern Biotech Announces Home DNA Testing Kits Availability for Paternity Test in India
Eastern Biotech to Launch Paternity Testing Services in India
Eastern Biotech to Promote deCODE Genetics’ DNA-based Tests for Assessing Risk of Diabetes and Other
DNA-DX Launches 'Genetic Art: The Most Exclusive Art Form'
Eastern Biotech Introduces Paternity Testing – Peace of Mind Test in Middle East
Eastern Biotech Announces Newborn Screening in Dubai
Eastern Biotech Launches Website in Arabic
CancerSafe Test which is Panel of Tumor Markers for Women and Men Now Availlable in Middle East
Eastern Biotech Introduces BRCA and Other Genetic Screening in Middle East
New Wall Chart for Family Ancestry in Arabic Launched
Eastern Biotech & Life Sciences Introduces Comprehensive Cardiovascular Assessment in UAE
Eastern Biotech & Life Sciences Launches Series of Rapid Diagnostic Kits in India
Eastern Biotech Announces Availability of Home Testing Kits for Predictive Genetics Test in the Middle East

Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  JobsWare.com

Visit  BizJobs.com










 
  ©2012 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri- bution today investor relation successful internet entrepreneur free newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)